The study of one hundred and twenty (120) independent participants, showed that total cholesterol (TC), Triglycerides (TG), and high-density cholesterol (HDL) evaluations, for both Venous blood (VB) and capillary blood (CB) specimen samples had 100% accuracy within 15% absolute bias in comparison to laboratory method (Roche Cobas c111) The PixoTest POCT System, measured TC, TG, and HDL with one sample specimen in a single test, drastically simplified the evaluation of patient blood lipid levels. The latest clinical study, Performance Evaluation of a New Mobile POC lipids Analyzer(1), published in the Journal of Medical and Biological Engineering (JMBE), proved that PixoTest POCT Lipid Analyzer had an accuracy comparable to laboratory method ( Roche Cobas c111). The paper indicated that the PixoTest® POCT System was capable of conducting accurate and reliable lipid measurements in the Point-Of-Care setting to increase healthcare efficacy and efficiency. Furthermore, PixoTest® POCT System overcame disadvantages such as the source of blood sample and inaccuracy when compared to laboratory examinations by existing POC devices in the market. iXensor believes that PixoTest® POCT system, can help healthcare professional to control patients’ cardiovascular disease (CVD) more efficiently, thanks to its handheld size portability that can be brought to where patients are, while delivering prompt results meeting lab-level accuracy. About iXensor: iXensor is a new generation health technology company that integrates medical engineering, biochemistry, and information technology expertise to develop the PixoTech® platform for connected smart healthcare. Based on it, iXensor created PixoTest®, the world first FDA approved smartphone camera-based blood test system for health care in 2017 that can deliver quick and accurate results in the areas of chronic illness, women’s health, and infectious disease management by using smartphone technology.

Read the article here